Related references
Note: Only part of the references are listed.Dopamine promotes the neurodegenerative potential of β-synuclein
Anupam Raina et al.
JOURNAL OF NEUROCHEMISTRY (2021)
Reverse engineering Lewy bodies: how far have we come and how far can we go?
Mohamed Bilal Fares et al.
NATURE REVIEWS NEUROSCIENCE (2021)
Comparison of induced neurons reveals slower structural and functional maturation in humans than in apes
Maria Schoernig et al.
ELIFE (2021)
Neuroprotective effects of garlic extract on dopaminergic neurons of substantia nigra in a rat model of Parkinson's disease: motor and non-motor outcomes
Maryam Bigham et al.
METABOLIC BRAIN DISEASE (2021)
Administration of quercetin improves mitochondria quality control and protects the neurons in 6-OHDA-lesioned Parkinson's disease models
Wen-Wen Wang et al.
AGING-US (2021)
The LRRK2 G2019S mutation alters astrocyte-to-neuron communication via extracellular vesicles and induces neuron atrophy in a human iPSC-derived model of Parkinson's disease
Aurelie de Rus Jacquet et al.
ELIFE (2021)
Generation of two gene edited iPSC-lines carrying a DOX-inducible NGN2 expression cassette with and without GFP in the AAVS1 locus
Benjamin Schmid et al.
STEM CELL RESEARCH (2021)
BANP opens chromatin and activates CpG-island-regulated genes
Ralph S. Grand et al.
NATURE (2021)
Stem cell-derived neurons reflect features of protein networks, neuropathology, and cognitive outcome of their aged human donors
Valentina N. Lagomarsino et al.
NEURON (2021)
SETBP1 accumulation induces P53 inhibition and genotoxic stress in neural progenitors underlying neurodegeneration in Schinzel-Giedion syndrome
Federica Banfi et al.
NATURE COMMUNICATIONS (2021)
Efficient generation of dopaminergic induced neuronal cells with midbrain characteristics
Yi Han Ng et al.
STEM CELL REPORTS (2021)
A Multistep Workflow to Evaluate Newly Generated iPSCs and Their Ability to Generate Different Cell Types
Carol X-Q Chen et al.
METHODS AND PROTOCOLS (2021)
Human autologous iPSC-derived dopaminergic progenitors restore motor function in Parkinson's disease models
Bin Song et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
The future of stem cell therapies for Parkinson disease
Malin Parmar et al.
NATURE REVIEWS NEUROSCIENCE (2020)
Classification of Midbrain Dopamine Neurons Using Single-Cell Gene Expression Profiling Approaches
Jean-Francois Poulin et al.
TRENDS IN NEUROSCIENCES (2020)
Development and Differentiation of Midbrain Dopaminergic Neuron: From Bench to Bedside
Mengmeng Wang et al.
CELLS (2020)
Toward Generating Subtype-Specific Mesencephalic Dopaminergic Neuronsin vitro
Tiago Cardoso et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
Single-Cell Transcriptomics of Parkinson's Disease Human In Vitro Models Reveals Dopamine Neuron-Specific Stress Responses
Hugo J. R. Fernandes et al.
CELL REPORTS (2020)
Microglia-Secreted Factors Enhance Dopaminergic Differentiation of Tissue- and iPSC-Derived Human Neural Stem Cells
Sissel Ida Schmidt et al.
STEM CELL REPORTS (2020)
Cryopreservation of Human Midbrain Dopaminergic Neural Progenitor Cells Poised for Neuronal Differentiation
Nicola J. Drummond et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
N-acetyl-cysteine blunts 6-hydroxydopamine- and l-buthionine-sulfoximine-induced apoptosis in human mesenchymal stromal cells
A. R. Bonilla-Porras et al.
MOLECULAR BIOLOGY REPORTS (2019)
A Single-Cell Model for Synaptic Transmission and Plasticity in Human iPSC-Derived Neurons
Marieke Meijer et al.
CELL REPORTS (2019)
Specific factors in blood from young but not old mice directly promote synapse formation and NMDA-receptor recruitment
Kathlyn J. Gan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Biophysical Properties of Somatic and Axonal Voltage-Gated Sodium Channels in Midbrain Dopaminergic Neurons
Jun Yang et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2019)
Differentiation of lymphoblastoid-derived iPSCs into functional cardiomyocytes, neurons and myoblasts
Hugo Poulin et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)
Homogenous generation of dopaminergic neurons from multiple hiPSC lines by transient expression of transcription factors
Sameehan Mahajani et al.
CELL DEATH & DISEASE (2019)
Single-Cell Sequencing of iPSC-Dopamine Neurons Reconstructs Disease Progression and Identifies HDAC4 as a Regulator of Parkinson Cell Phenotypes
Charmaine Lang et al.
CELL STEM CELL (2019)
Ketamine increases the expression of GluR1 and GluR2 α-amino-3-hydroxy-5-methy-4-isoxazole propionate receptor subunits in human dopaminergic neurons differentiated from induced pluripotent stem cells
Ginetta Collo et al.
NEUROREPORT (2019)
Synthetic mRNAs Drive Highly Efficient iPS Cell Differentiation to Dopaminergic Neurons
Yingchao Xue et al.
STEM CELLS TRANSLATIONAL MEDICINE (2019)
Patient-Specific iPSC-Derived Astrocytes Contribute to Non-Cell-Autonomous Neurodegeneration in Parkinson's Disease
Angelique di Domenico et al.
STEM CELL REPORTS (2019)
Role of Dopamine D2/D3 Receptors in Development, Plasticity, and Neuroprotection in Human iPSC-Derived Midbrain Dopaminergic Neurons
Federica Bono et al.
MOLECULAR NEUROBIOLOGY (2018)
APOE4 Causes Widespread Molecular and Cellular Alterations Associated with Alzheimer's Disease Phenotypes in Human iPSC-Derived Brain Cell Types
Yuan-Ta Lin et al.
NEURON (2018)
Combining NGN2 Programming with Developmental Patterning Generates Human Excitatory Neurons with NMDAR-Mediated Synaptic Transmission
Ralda Nehme et al.
CELL REPORTS (2018)
Directed Differentiation of Dopamine-Secreting Cells from Nurr1/GPX1 Expressing Murine Embryonic Stem Cells Cultured on Matrigel-Coated PCL Scaffolds
Panieh Terraf et al.
MOLECULAR NEUROBIOLOGY (2017)
Pikuni-Blackfeet traditional medicine: Neuroprotective activities of medicinal plants used to treat Parkinson's disease-related symptoms
Aurelie de Rus Jacquet et al.
JOURNAL OF ETHNOPHARMACOLOGY (2017)
Lumbee traditional medicine: Neuroprotective activities of medicinal plants used to treat Parkinson's disease-related symptoms
Aurelie de Rus Jacquet et al.
JOURNAL OF ETHNOPHARMACOLOGY (2017)
Efficient Generation of Dopamine Neurons by Synthetic Transcription Factor mRNAs
Sang-Mi Kim et al.
MOLECULAR THERAPY (2017)
Human iPS cell-derived dopaminergic neurons function in a primate Parkinson's disease model
Tetsuhiro Kikuchi et al.
NATURE (2017)
MHC matching improves engraftment of iPSC-derived neurons in non-human primates
Asuka Morizane et al.
NATURE COMMUNICATIONS (2017)
MAPT Genetic Variation and Neuronal Maturity Alter Isoform Expression Affecting Axonal Transport in iPSC-Derived Dopamine Neurons
Joel E. Beevers et al.
STEM CELL REPORTS (2017)
Parkinson disease
Werner Poewe et al.
NATURE REVIEWS DISEASE PRIMERS (2017)
Rapid Ngn2-induction of excitatory neurons from hiPSC-derived neural progenitor cells
Seok-Man Ho et al.
METHODS (2016)
Aldehyde dehydrogenase 1 defines and protects a nigrostriatal dopaminergic neuron subpopulation
Guoxiang Liu et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Physiological Characterisation of Human iPS-Derived Dopaminergic Neurons
Elizabeth M. Hartfield et al.
PLOS ONE (2014)
A Time Course Analysis of the Electrophysiological Properties of Neurons Differentiated from Human Induced Pluripotent Stem Cells (iPSCs)
Deborah Pre et al.
PLOS ONE (2014)
Functional differentiation of midbrain neurons from human cord blood-derived induced pluripotent stem cells
Nancy Stanslowsky et al.
STEM CELL RESEARCH & THERAPY (2014)
iPSC-Derived Dopamine Neurons Reveal Differences between Monozygotic Twins Discordant for Parkinson's Disease
Chris M. Woodard et al.
CELL REPORTS (2014)
Isolation of Human Induced Pluripotent Stem Cell-Derived Dopaminergic Progenitors by Cell Sorting for Successful Transplantation
Daisuke Doi et al.
STEM CELL REPORTS (2014)
Animal Models of Parkinson's Disease: Limits and Relevance to Neuroprotection Studies
Erwan Bezard et al.
MOVEMENT DISORDERS (2013)
100 years of Lewy pathology
Michel Goedert et al.
NATURE REVIEWS NEUROLOGY (2013)
Rapid Single-Step Induction of Functional Neurons from Human Pluripotent Stem Cells
Yingsha Zhang et al.
NEURON (2013)
Improved Cell Therapy Protocols for Parkinson's Disease Based on Differentiation Efficiency and Safety of hESC-, hiPSC-, and Non-Human Primate iPSC-Derived Dopaminergic Neurons
Maria Sundberg et al.
STEM CELLS (2013)
Efficient Generation of A9 Midbrain Dopaminergic Neurons by Lentiviral Delivery of LMX1A in Human Embryonic Stem Cells and Induced Pluripotent Stem Cells
A. Sanchez-Danes et al.
HUMAN GENE THERAPY (2012)
Fiji: an open-source platform for biological-image analysis
Johannes Schindelin et al.
NATURE METHODS (2012)
NEUROTOXIN-BASED MODELS OF PARKINSON'S DISEASE
J. Bove et al.
NEUROSCIENCE (2012)
Quercetin and Sesamin Protect Dopaminergic Cells from MPP+-Induced Neuroinflammation in a Microglial (N9)-Neuronal (PC12) Coculture System
Julie Bournival et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2012)
Parkin controls dopamine utilization in human midbrain dopaminergic neurons derived from induced pluripotent stem cells
Houbo Jiang et al.
NATURE COMMUNICATIONS (2012)
Generation of Regionally Specified Neural Progenitors and Functional Neurons from Human Embryonic Stem Cells under Defined Conditions
Agnete Kirkeby et al.
CELL REPORTS (2012)
Specific and integrated roles of Lmx1a, Lmx1b and Phox2a in ventral midbrain development
Qiaolin Deng et al.
DEVELOPMENT (2011)
Quercetin exerts a neuroprotective effect through inhibition of the iNOS/NO system and pro-inflammation gene expression in PC12 cells and in zebrafish
Zai Jun Zhang et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2011)
Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson's disease
Sonja Kriks et al.
NATURE (2011)
A more efficient method to generate integration-free human iPS cells
Keisuke Okita et al.
NATURE METHODS (2011)
The Physiology, Signaling, and Pharmacology of Dopamine Receptors
Jean-Martin Beaulieu et al.
PHARMACOLOGICAL REVIEWS (2011)
Robust Pacemaking in Substantia Nigra Dopaminergic Neurons
Jaime N. Guzman et al.
JOURNAL OF NEUROSCIENCE (2009)
Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling
Stuart M. Chambers et al.
NATURE BIOTECHNOLOGY (2009)
Human Induced Pluripotent Stem Cells Free of Vector and Transgene Sequences
Junying Yu et al.
SCIENCE (2009)
Foxa2: The rise and fall of dopamine neurons
Ernest Arenas
CELL STEM CELL (2008)
Specification of a Dopaminergic phenotype from adult human mesenchymal stem cells
Katarzyna A. Trzaska et al.
STEM CELLS (2007)
Functional engraftment of human ES cell-derived dopaminergic neurons enriched by coculture with telomerase-immortalized midbrain astrocytes
Neeta S. Roy et al.
NATURE MEDICINE (2006)
Pitx3 regulates tyrosine hydroxylase expression in the substantia nigra and identifies a subgroup of mesencephalic dopaminergic progenitor neurons during mouse development
SL Maxwell et al.
DEVELOPMENTAL BIOLOGY (2005)
Effects of 6-hydroxydopamine on primary cultures of substantia nigra: specific damage to dopamine neurons and the impact of glial cell line-derived neurotrophic factor
YM Ding et al.
JOURNAL OF NEUROCHEMISTRY (2004)
The vesicular amine transporter family (SLC18):: amine/proton antiporters required for vesicular accumulation and regulated exocytotic secretion of monoamines and acetylcholine
LE Eiden et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2004)
Bi-directional effects of GABAB receptor agonists on the mesolimbic dopamine system
HG Cruz et al.
NATURE NEUROSCIENCE (2004)
Fate of midbrain dopaminergic neurons controlled by the engrailed genes
HH Simon et al.
JOURNAL OF NEUROSCIENCE (2001)
Molecular and functional heterogeneity of hyperpolarization-activated pacemaker channels in the mouse CNS
B Santoro et al.
JOURNAL OF NEUROSCIENCE (2000)
Share Paper
